Coordinated Communication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)
Official title: CONNECT-AKI: COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury - A Pilot Randomized Controlled Trial
Run by Northwell Health · NCT07626268 · Data updated 2026-11-12
This study tests whether a discharge summary template and a chat-based education program help adults with AKI understand their condition and follow up after leaving the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Northwell Health Academic / other |
| Locations | 2 sites (Glen Oaks, New York and 1 other locations) |
| Status | Recruiting |
| Started | June 24, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | October 30, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07626268 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who were hospitalized with stage 2 or 3 AKI, have not returned to baseline kidney function at discharge, and can communicate in English.
✕Probably not a fit
Patients without AKI or those who are unable to participate in English-language procedures or provide consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot randomized trial compares four care-transition approaches for adults hospitalized with AKI: usual care, an AKI discharge summary template, a chat-based educational messaging program, and both interventions together. The study evaluates feasibility, acceptability, patient knowledge, perceived preparedness, and completion of recommended follow-up after discharge. Participants complete questionnaires and researchers review medical records to assess communication and care transitions. The intervention aims to improve information sharing with outpatient clinicians and patient understanding after discharge.
Why it matters
Potential benefit: If successful, the program could improve patient knowledge and preparedness and reduce post-discharge complications or unnecessary readmissions.
How similar studies have gone: Prior care-transition studies in AKI have shown promise for improved communication and follow-up, but this specific multi-arm approach is exploratory in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Hospitalized with Stage 2 or Stage 3 acute kidney injury * Kidney function has not returned to baseline at the time of hospital discharge * Able to communicate in English * Able to provide informed consent * Willing and able to participate in study procedures independently or with assistance from a patient-designated care partner Exclusion Criteria: * Acute kidney injury requiring ongoing dialysis at the time of hospital discharge * End-stage kidney disease * Kidney transplant recipient * Currently pregnant * Documented cognitive impairment that precludes informed consent * Receiving hospice or comfort-focused end-of-life care
Where it's running
-
Long Island Jewish Medical Center
Glen Oaks, New York, United States Recruiting -
North Shore University Hospital
Manhasset, New York, United States Recruiting
Study contacts
- Principal investigator: Jia Hwei Ng, MD, MSCE — Northwell Health
- Study coordinator: Jia Hwei Ng, MD, MSCE
- Email: jng10@northwell.edu
- Phone: 516-465-8200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hamburg Acute Renal Injury (HARIS) cohort
This project will follow adults hospitalized with AKI and a group of similar hospitalized patients without AKI to test which clinical factors and blood or urine markers predict recovery and longer-term kidney and cardiovascular problems.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Biomarkers to predict CSA-AKI risk before heart surgery
This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI
This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.